Litcius/Paper detail

Abrocitinib‐A promising option for patients with refractory bullous pemphigoid

Weiwei Jiang, Xiuliang Ma, Tao Guo, Mengmeng Song, Junling Zhang

2023Journal of the European Academy of Dermatology and Venereology12 citationsDOI

Abstract

The data that supports the findings of this study are available within the paper.

Topics & Concepts

MedicineDermatologyChinaTraditional medicineHistoryArchaeologyAutoimmune Bullous Skin DiseasesUrticaria and Related ConditionsDermatology and Skin Diseases
Abrocitinib‐A promising option for patients with refractory bullous pemphigoid | Litcius